Madsbad, Sten

Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes

Toft-Nielsen, M.-B., Madsbad, S., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 164

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

Leiter, L. A., Bain, S. C., Hramiak, I., Jódar, E., Madsbad, S., Gondolf, T., Hansen, T., Holst, I., & Lingvay, I. (2019) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 159

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018) · Cell Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 156

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

Jensen, S. B. K., Sørensen, V., Sandsdal, R. M., Lehmann, E. W., Lundgren, J. R., Juhl, C. R., Janus, C., Ternhamar, T., Stallknecht, B. M., Holst, J. J., et al. (2024) · JAMA Network Open

Bone health and osteoporosis researchHIV-related health complications and treatments

Cited by 155

The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications

Madsbad, S. (2014) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 146

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Kielgast, U., Holst, J. J., & Madsbad, S. (2011) · Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 137

Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia

Toft-Nielsen, M., Madsbad, S., & Holst, J. J. (1998) · Diabetologia

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 132

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J.-E., Pedersen, O., Hansen, T., Madsbad, S., Holst, J. J., & Torekov, S. S. (2015) · International Journal of Obesity

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 118

The effect of intense exercise on postprandial glucose homeostasis in type II diabetic patients

Larsen, J. J. S., Dela, F., Madsbad, S., & Galbo, H. (1999) · Diabetologia

Diabetes Management and ResearchPhysical Activity and Health

Cited by 112

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Twelve-week treatment with liraglutide as add-on to insulin in normal-weight patients with poorly controlled type 1 diabetes: a randomized, placebo-controlled, double-blind parallel study

Frandsen, C. S., Dejgaard, T. F., Holst, J. J., Andersen, H. U., Thorsteinsson, B., & Madsbad, S. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 103

Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36

Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S., & Torekov, S. S. (2016) · European Journal of Endocrinology

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 101

Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: Arandomized open‐label crossover trial

Ranjan, A., Schmidt, S., Damm‐Frydenberg, C., Holst, J. J., Madsbad, S., & Nørgaard, K. (2017) · Diabetes, Obesity and Metabolism

Diet and metabolism studiesDiabetes Management and Research

Cited by 101

Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Kumarathurai, P., Anholm, C., Larsen, B. S., Olsen, R. H., Madsbad, S., Kristiansen, O., Nielsen, O. W., Haugaard, S. B., & Sajadieh, A. (2017) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes Treatment and Management

Cited by 96

Link between GIP and osteopontin in adipose tissue and insulin resistance

Ahlqvist, E., Osmark, P., Kuulasmaa, T., Pilgaard, K., Omar, B., Brøns, C., Kotova, O., Zetterqvist, A. V., Stančáková, A., Jonsson, A., et al. (2013) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesBone Metabolism and Diseases

Cited by 96

Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study

Ranjan, A., Schmidt, S., Damm-Frydenberg, C., Steineck, I., Clausen, T. R., Holst, J. J., Madsbad, S., & Nørgaard, K. (2017) · Diabetes Care

Diabetes Management and ResearchDiet and metabolism studies

Cited by 89

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Højberg, P. V., Zander, M., Vilsbøll, T., Knop, F. K., Krarup, T., Vølund, A., Holst, J. J., & Madsbad, S. (2008) · Diabetologia

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 89

Metformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration

Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia

Metabolism, Diabetes, and CancerMitochondrial Function and Pathology

Cited by 81

Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

Anholm, C., Kumarathurai, P., Pedersen, L. R., Samkani, A., Walzem, R. L., Nielsen, O. W., Kristiansen, O. P., Fenger, M., Madsbad, S., Sajadieh, A., et al. (2019) · Atherosclerosis

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 75

Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.

Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Andersen, J. L., Madsbad, S., Worm, D., Helge, J. W., & Dela, F. (2011) · Diabetologia

Mitochondrial Function and PathologyAdipose Tissue and Metabolism

Cited by 73

Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.

Rabøl, R., Højberg, P. M. V., Almdal, T., Boushel, R., Haugaard, S. B., Madsbad, S., & Dela, F. (2009) · The Journal of Clinical Endocrinology & Metabolism

Mitochondrial Function and PathologyMetabolism, Diabetes, and Cancer

Cited by 66

Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients

Larsen, J. J., Dela, F., Madsbad, S., Vibe-Petersen, J., & Galbo, H. (1999) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 62

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Rehfeld, J. F., Knop, F. K., Asmar, A., Madsbad, S., Holst, J. J., & Asmar, M. (2018) · Scandinavian Journal of Gastroenterology

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 62

Four weeks of near‐normalization of blood glucose has no effect on postprandial GLP‐1 and GIP secretion, but augments pancreatic B‐cell responsiveness to a meal in patients with Type 2 diabetes

Højberg, P. V., Vilsbøll, T., Zander, M., Knop, F. K., Krarup, T., Vølund, A., Holst, J. J., & Madsbad, S. (2008) · Diabetic Medicine

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 56